# Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration

> **NCT02339987** · — · TERMINATED · sponsor: **Saint John's Cancer Institute** · enrollment: 27 (actual)

## Conditions studied

- Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02339987
- **Lead sponsor:** Saint John's Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2018-06-04
- **Final completion:** 2018-06-04
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** original PI left institute, no plan to continue using samples
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02339987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02339987, "Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02339987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*